|
|
40
|
|
|
B031AN
|
|
|
EFAVIRENZ 600MG TAB (MCP/AHI)
|
|
|
EFAVIRENZ
|
|
|
EFAVIRENZ
|
|
|
30'S
|
|
|
BL
|
|
|
9.08
|
|
|
0.30
|
|
|
600MG
|
|
|
TABLET
|
|
|
0
|
|
|
TAB
|
|
|
MCP
|
|
|
MACLEODS PHARMACEUTICALS LTD
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No
|
|
|
08180816
|
|
|
NNRTI
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
ANTI-INFECTIVE AGENTS
|
|
|
|